DEPLETION OF CD103 EXPRESSING CELLS FOR TREATMENT OF DISORDERS

摘要

The present invention relates to methods of selectively depleting CD103+ cells in vivo in a subject, with the methods comprising administering a composition comprising an anti-CD103 antibody conjugated to a lethal compound to the subject.